GSK Shingles Vaccine Shingrix Gets First Okay in Canada GSK Shingles Vaccine Shingrix Gets First Okay in Canada
Shingrix, given in two doses 2 to 6 months apart, is for adults aged 50 years and older. It was shown to achieve ≥ 90% efficacy in clinical trials.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news
More News: Canada Health | Clinical Trials | Health | Infectious Diseases | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines